The EBS Market central limit order book is widely regarded as the primary market for major spot FX pairs and Asian non-deliverable forward (NDFs), including the one-month outright in Taiwanese dollar (TWD). A unique aspect to our marketplace is genuine order flow coming together from a truly manual customer base, sat across trading institutions globally.

In August 2023, EBS Market launched the Size Priority Matching Algorithm in the TWD NDF pair, incentivizing the placement of orders with larger shown inventory, while maintaining price improvers’ position at the front of queue. When shown to the market, these larger orders reinforce depth of book, resilience of liquidity and can reduce market impact from trades. Since the release of the matching logic change, EBS has noted the following positive results from the OFF SEF TWD NDF order book:

  • 11% increase in orders of notional $3 million and above
  • 6% increase in average order size
  • 10% increase in Top of Book inventory between the hours of 00:00 - 10:00 GMT  

These are early indications that emerging market FX traders on EBS Market TWD NDF have adopted an approach to show greater inventory, and the feedback from customers has been encouraging.

In addition, increased market activity led to November 2023 being the highest traded volume month for USD/TWD one-month outright NDF on EBS Market, and November 21 the all-time record volume day for OFF-SEF USD/TWD NDF with $3.76 billion traded.

By bringing genuine liquidity together, and prioritizing larger notional interest in the order book, EBS Market looks to further enrich depth of liquidity, and consequently reduce market impact of trading activity.

To learn more or to connect to EBS Market, contact

EBS Market

Trade on our trusted primary market and experience an anonymous matching platform and world-class market data.

The content in this communication has been compiled by CME Group for general purposes only and is not intended to provide, and should not be construed as, advice. Although every attempt has been made to ensure the accuracy of the information within this communication as of the date of publication, CME Group assumes no responsibility for any errors or omissions and will not update it. Additionally, all examples and information in this communication are used for explanation purposes only and should not be considered investment advice or the results of actual market experience. This communication does not (within the meaning of any applicable legislation) constitute a Prospectus or a public offering of securities; nor is it a recommendation to buy, sell or retain any specific investment or service.

CME Group does not represent that any material or information contained in this communication is appropriate for use or permitted in any jurisdiction or country where such use or distribution would be contrary to any applicable law or regulation. In any jurisdiction where CME Group is not authorized to do business or where such distribution would be contrary to the local laws and regulations, this communication has not been reviewed or approved by any regulatory authority and access shall be at the liability of the user.

Certain CME Group subsidiaries are authorised and regulated by regulatory authorities. Certain of those subsidiaries are required to retain records of telephone conversations and other electronic communications for a period of 5 to 7 years where required by certain regulation, copies of which are available on request (which may be subject to a fee). For further regulatory information please see

BrokerTec Europe Limited is authorized and regulated by the UK Financial Conduct Authority.

NEX SEF Limited is authorized and regulated by the UK Financial Conduct Authority and is registered with the CFTC as a Swap Exchange Facility.

CME Amsterdam B.V. is regulated in the Netherlands by the Dutch Authority for the Financial Markets (AFM) (

BrokerTec Americas LLC. (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (, and is a member of the Securities Investor Protection Corporation ( BAL does not provide services to private or retail customers.

Mailing Address: 20 South Wacker Drive, Chicago, Illinois 60606

Copyright © 2023 CME Group Inc. All rights reserved.

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2024 CME Group Inc. All rights reserved.